← Therapeutics
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry-results+publication
University of Michigan Soundbites micronutrient NIHL prevention study
Also known as: Beta-Carotene, Vitamins C And E, Magnesium, Soundbites, Soundbites dietary supplement, Micronutrients to Prevent Noise-induced Hearing Loss, NCT00808470, U01DC008423
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Therapeutic
Modality
Small Molecule
Stage
Phase 2
Status
Completed
Target Gene
—
Route / Mode
Oral dietary supplement tablets
Confidence
86%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-09
Geography
United States
Population
adult, healthy-volunteer, noise-induced, otoprotection, dietary-supplement
Trial IDs
1
Mechanism
Oral micronutrient combination of beta-carotene, vitamins C and E, and magnesium tested for prevention of temporary music-induced threshold shifts/noise-induced hearing changes.
Indications
Notes
Corrected from an EuHearing-owned row. ClinicalTrials.gov lists University of Michigan as lead sponsor and Hearing Health Science, Inc. as an unknown-class collaborator. Results are posted, and the cited Audiology & Neurotology Extra publication reports failure to prevent music-induced temporary threshold shift.
Evidence & Sources
2 structured sourcesKey Events
Clinical Trials (1)
Data Checks
institution-led-studycompleted-studyresults-postednegative-primary-evidencenot-active-product-program
Related Programs
Otarmeni by Regeneron
Company: Regeneron Pharmaceuticals · Gene Therapy · Approved
PEDMARK by Fennec Pharmaceuticals
Company: Fennec Pharmaceuticals · Small Molecule · Marketed
AK-OTOF by Eli Lilly and Akouos
Company: Eli Lilly and Company · Gene Therapy · Phase 2
SENS-401 (Arazasetron) by Sensorion
Company: Sensorion · Small Molecule · Phase 2
SENS-501 by Sensorion
Company: Sensorion · Gene Therapy · Phase 1/2
Rincell-1 by Rinri Therapeutics
Company: Rinri Therapeutics · Cell Therapy · Phase 1/2